Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Click here to unsubscribe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• Caffeine increases IOP
• Corneal refractive therapy lenses
• Statins reduce OAG risk
• Pegaptanib is efficacious and non-toxic
 
 
Survey

Would you use pegaptanib combined with laser therapy for treating retinopathy of prematurity?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
August 23, 2012
Caffeine increases IOP and OPP in POAG
Consuming one cup of caffeinated coffee statistically increases IOP and ocular perfusion pressure (OPP) in primary open-angle glaucoma (POAG) patients. More...
Lenses linked to increased inflammatory markers
Tear levels of inflammatory markers increase in patients who wear corneal refractive therapy lenses, compared to those who wore silicone-hydrogel lenses or no lenses. More...
City Guide
Continuing Ophthalmology Times Europe's series of City Guides, Seeing Milan, sponsored by Oertli, will help you get the most out of your stay. To read more please click here
Statins reduce OAG risk in hyperlipidemia
The use of statins has been linked to a significant decrease in open-angle glaucoma (OAG) risk in patients with hyperlipidemia. More...
Pegaptanib efficacious and non-toxic for ROP
Anti-VEGF therapy pegaptanib is efficacious and non-toxic for patients with retinopathy of prematurity (ROP), states a recent study. More...